• Citer

Sitaxsentan for the treatment of pulmonary arterial hypertension: A 1-year, prospective, open-label observation of outcome and survival

par Benza, Raymond L.;Barst, Robyn J.;Galie, Nazzareno;Frost, Adaani;Girgis, Reda E.;Highland, Kristin B.;Strange, Charlie;Black, Carol M.;Badesch, David B.;Rubin, Lewis;Fleming, Thomas R.;Naeije, Robert
Référence Chest, 134, 4, page (775-782)
Publication Publié, 2008-10

Article révisé par les pairs

• Détails

Titre:	Sitaxsentan for the treatment of pulmonary arterial hypertension: A 1-year, prospective, open-label observation of outcome and survival
Auteur:	Benza, Raymond L.; Barst, Robyn J.; Galie, Nazzareno; Frost, Adaani; Girgis, Reda E.; Highland, Kristin B.; Strange, Charlie; Black, Carol M.; Badesch, David B.; Rubin, Lewis; Fleming, Thomas R.; Naeije, Robert
Informations sur la publication:	Chest, 134, 4, page (775-782)
Statut de publication:	Publié, 2008-10
Sujet CREF:	Cardiologie et circulation
	Pneumologie
	Sciences bio-médicales et agricoles
Mots-clés:	Bosentan
	Endothelin antagonists
	Pulmonary arterial hypertension
	Sitaxsentan
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0012-3692
	info:doi/10.1378/chest.07-0767
	info:scp/54249126566